SLIT mutations as potential predictive biomarkers for immunotherapy in NSCLC

Ethics approval and consent to participate

Since the study is based on public data, the informed consent and ethical proof are not required. All authors give their consent to publish this manuscript.

Competing interests

The authors declare that they have no competing interests.

留言 (0)

沒有登入
gif